MyHeart

  • Home
  • About Us
    • Our Team
    • Authors
  • Resources
    • MitraClip University
      • Advanced Steering
    • POTS Center
    • Heart Healthy Nutrition
    • MyHeart Videos
  • Articles
  • Podcasts
  • Contact Us
  • Advertising
Home / Featured Articles / THE CHRONIC LEAKY MITRAL VALVE

THE CHRONIC LEAKY MITRAL VALVE

December 30, 2022 by Alain Bouchard, MD Leave a Comment

This article was written in collaboration with Dr. Mustafa Ahmed, Associate Professor of Medicine, Director of the Structural and Interventional Cardiology Program at the University of Alabama, at Birmingham.

CHRONIC MITRAL INSUFFICIENCY:

In this report, we would like to concentrate on the primary mitral insufficiency which is a disease of the mitral valve apparatus (mitral leaflet, chordae tendineae, papillary muscle, mitral annulus), and not the secondary cause which is a disease of the left ventricle and/or the left atrium. The most common cause in the US is mitral valve prolapse.

The severity of the valve insufficiency is based on several criteria that include symptoms, valve anatomy, hemodynamics, and the effect of the insufficiency on ventricular and pulmonary vasculature function. The criteria for severe valve regurgitation are based on predictors of clinical outcomes obtained from clinical trials and registries. Severity is a continuous variable and may manifest itself in different ways for different patients. The onset of symptoms represents an indication of valve repair. However, because the hemodynamic changes can occur over a long period of time, symptoms of shortness of breath or decreased exercise tolerance can be missed or ignored by the patients. Exercise testing or biomarkers (BNP or NT-proBNP) can be helpful in determining the severity of the valve lesion. 

Echocardiographic images provide the ideal non-invasive testing to study mitral valve pathology, the severity of the lesion, and its impact on the left ventricle. Because the leaky mitral valve empties into a low-pressure chamber (left atrium), the EF appears better than normal and an EF of >70% is considered normal. When the extra volume load starts affecting the LV function, the EF starts declining toward 60% and the LV can no longer contract to an end-systolic diameter of <40 mm. The Doppler evaluation of the severity of the regurgitation should integrate all the variables documented by the examination: Color jet area (how far back it reaches into the LA), vena contracta (>0.7 cm), effective regurgitant orifice area (EROA >0.4 cm2), regurgitant volume (>60 mL) and a regurgitant fraction (>50%). In mitral valve prolapse, the regurgitant jet may not be holosystolic and the maximal doppler regurgitant jet may overestimate the severity of the lesion. Volumetric calculation of regurgitant volume may be more accurate in those circumstances particularly if 3D data is analyzed either from Echocardiography or magnetic resonance. 

Transesophageal echocardiography using 3D imaging allows for visualization of abnormal mitral valve leaflets providing a “surgical view” of the valve and offering a better understanding of the anatomy and estimation of the likelihood of surgical repair. Decision-making can be challenging in an asymptomatic patient and requires the involvement of the Heart Team approach. Consideration should be given to referring patients to a Comprehensive Heart Valve Center where the operative morbidity and mortality are very low and where a durable surgical outcome is very high.

5/5 (3)

Tell Us How We're Doing...

Filed Under: Featured Articles, Heart Valves

Leave a Reply Cancel reply

Connect with:
Facebook Google Twitter
If you need immediate medical attention, please call 911. These comments are not guaranteed to be read in a timely manner and should not be used to seek immediate medical advice.

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Alain Bouchard, MD

Dr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at St. Vincent's Health System, Ascension.

View My Posts

Recent Posts

  • THE CHRONIC LEAKY MITRAL VALVE
  • Leaky Mitral Valve
  • THE CHRONIC LEAKY AORTIC VALVE
  • Leaky Aortic Valve
  • DOPPLER ECHOCARDIOGRAPHY: PAST, PRESENT, AND FUTURE

Categories

  • Aortic disease (7)
  • Featured Articles (64)
  • General Health (37)
  • Heart Disease (176)
    • Cardiac Arrhythmias (17)
    • Coronary Artery Disease (51)
    • Heart Failure and Cardiomyopathies (29)
    • Heart Valves (46)
  • Heart Health (111)
    • Diet & Nutrition (36)
    • Exercise (34)
    • Risk & Prevention (54)
  • Medical News (9)
  • Podcast (63)
  • Tests & Investigations (28)
  • Uncategorized (3)
  • Vascular Disease (27)
    • Hypertension (High Blood Pressure) (14)
RECENT POSTS
  • THE CHRONIC LEAKY MITRAL VALVE
  • Leaky Mitral Valve
  • THE CHRONIC LEAKY AORTIC VALVE
  • Leaky Aortic Valve
  • DOPPLER ECHOCARDIOGRAPHY: PAST, PRESENT, AND FUTURE
FOLLOW US
ABOUT MY HEART

MyHeart is a group of physicians dedicated to empowering patients to take control of their health. Read by over a million people every year, MyHeart is quickly becoming a “go to” resource for patients across the world.

POPULAR TOPICS ON MYHEART
  • POTS Syndrome Center
  • Earlobe Crease & Heart Disease
  • Atrial Fibrillation with RVR
  • STEMI
  • MitraClip
  • Mitral Regurgitation
NAVIGATION
  • Home
  • About Us
    • Our Team
    • Authors
  • Resources
    • MitraClip University
      • Advanced Steering
    • POTS Center
    • Heart Healthy Nutrition
    • MyHeart Videos
  • Articles
  • Podcasts
  • Contact Us
  • Advertising

Privacy Policy. Terms of Use.
© 2023 MyHeart. All rights reserved.
MyHeart is not a substitute for advice from a doctor. Read our medical disclaimer. Sitemap.